AURANOFIN VERSUS INJECTABLE GOLD - COMPARISON OF PHARMACOKINETIC PROPERTIES

被引：31

作者：

BLOCKA, K

机构：

来源：

AMERICAN JOURNAL OF MEDICINE | 1983年 / 75卷 / 6A期

关键词：

D O I：

10.1016/0002-9343(83)90483-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：114 / 122

页数：9

共 43 条

[1]

BERGLOF FE, 1978, J RHEUMATOL, V5, P68

[2]

BERTRAND JJ, 1948, J LAB CLIN MED, V33, P1133

[3]

BIGGS DF, 1979, J RHEUMATOL, V6, P68

[4] METABOLISM OF GOLD DURING LACTATION [J].

BLAU, SP .

ARTHRITIS AND RHEUMATISM, 1973, 16 (06) :777-778

[5]

BLOCKA K, 1982, J RHEUMATOL, V9, P110

[6] SERUM GOLD .1. ESTIMATION BY ATOMIC-ABSORPTION SPECTROSCOPY [J].

DIETZ, AA ;

RUBINSTEIN, HM .

ANNALS OF THE RHEUMATIC DISEASES, 1973, 32 (02) :124-127

[7] AURANOFIN - NEW ORAL GOLD COMPOUND FOR TREATMENT OF RHEUMATOID-ARTHRITIS [J].

FINKELSTEIN, AE ;

WALZ, DT ;

BATISTA, V ;

MIZRAJI, M ;

ROISMAN, F ;

MISHER, A .

ANNALS OF THE RHEUMATIC DISEASES, 1976, 35 (03) :251-257

[8] Metabolism, toxicity and manner of action of gold compounds used in the treatment of arthritis. I. Human plasma and synovial fluid concentration and urinary excretion of gold during and following treatment with gold sodium thiomalate, gold sodium thiosulfate, and colloidal gold sulfide [J].

Freyberg, RH ;

Block, WD ;

Levey, S .

JOURNAL OF CLINICAL INVESTIGATION, 1941, 20 (04) :401-412

[9]

FREYBERG RH, 1979, ARTHRITIS ALLIED CON, P455

[10]

GERBER DA, 1964, J PHARMACOL EXP THER, V143, P137

← 1 2 3 4 5 →